Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lacteol Forte in Systemic Lupus Erythematosus
NCT05433857Phase 2Completed
- Sponsor
- Ain Shams University
- Start
- Jun 2022
- Primary completion
- Dec 2023
- Modality
- Live Biotherapeutic Products
- Countries
- 1
01
Overview
A Phase 2 trial of Lactobacillus LB in systemic lupus erythematosus (SLE), sponsored by Ain Shams University. Started Jun 2022; status: completed.
02
Drugs
Lactobacillus LB
03
Conditions
systemic lupus erythematosus (SLE)
Beyond the preview
Go deeper on NCT05433857.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05433857.